Surgery Partners, Inc.

NasdaqGS:SGRY Rapporto sulle azioni

Cap. di mercato: US$4.3b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Surgery Partners Performance dei guadagni passati

Il passato criteri di controllo 0/6

Surgery Partners ha registrato una crescita degli utili a un tasso medio annuo di 41%, mentre il settore Healthcare ha registrato utili in crescita a un tasso medio annuo di 7.1%. I ricavi sono stati in crescita a un tasso medio annuo di 10.9%.

Informazioni chiave

41.0%

Tasso di crescita degli utili

53.2%

Tasso di crescita dell'EPS

Healthcare Crescita del settore8.5%
Tasso di crescita dei ricavi10.9%
Rendimento del capitale proprio3.6%
Margine netto-1.2%
Ultimo aggiornamento sui guadagni30 Jun 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

Surgery Partners, Inc. (NASDAQ:SGRY) Soars 25% But It's A Story Of Risk Vs Reward

Jul 25
Surgery Partners, Inc. (NASDAQ:SGRY) Soars 25% But It's A Story Of Risk Vs Reward

Here's Why Surgery Partners (NASDAQ:SGRY) Has A Meaningful Debt Burden

Jul 13
Here's Why Surgery Partners (NASDAQ:SGRY) Has A Meaningful Debt Burden

Slowing Rates Of Return At Surgery Partners (NASDAQ:SGRY) Leave Little Room For Excitement

Jun 21
Slowing Rates Of Return At Surgery Partners (NASDAQ:SGRY) Leave Little Room For Excitement

We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

May 31
We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now

Surgery Partners, Inc.'s (NASDAQ:SGRY) Share Price Matching Investor Opinion

Apr 24
Surgery Partners, Inc.'s (NASDAQ:SGRY) Share Price Matching Investor Opinion

Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall

Mar 18
Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall

Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Feb 27
Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

The Price Is Right For Surgery Partners, Inc. (NASDAQ:SGRY)

Dec 19
The Price Is Right For Surgery Partners, Inc. (NASDAQ:SGRY)

Returns Are Gaining Momentum At Surgery Partners (NASDAQ:SGRY)

Oct 26
Returns Are Gaining Momentum At Surgery Partners (NASDAQ:SGRY)

Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Sep 17
Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Are Investors Undervaluing Surgery Partners, Inc. (NASDAQ:SGRY) By 35%?

Aug 26
Are Investors Undervaluing Surgery Partners, Inc. (NASDAQ:SGRY) By 35%?

The Return Trends At Surgery Partners (NASDAQ:SGRY) Look Promising

Jul 21
The Return Trends At Surgery Partners (NASDAQ:SGRY) Look Promising

Surgery Partners, Inc.'s (NASDAQ:SGRY) Shareholders Might Be Looking For Exit

Jun 15
Surgery Partners, Inc.'s (NASDAQ:SGRY) Shareholders Might Be Looking For Exit

A Look At The Intrinsic Value Of Surgery Partners, Inc. (NASDAQ:SGRY)

May 26
A Look At The Intrinsic Value Of Surgery Partners, Inc. (NASDAQ:SGRY)

There's Been No Shortage Of Growth Recently For Surgery Partners' (NASDAQ:SGRY) Returns On Capital

Apr 14
There's Been No Shortage Of Growth Recently For Surgery Partners' (NASDAQ:SGRY) Returns On Capital

Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet

Mar 24
Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet

Surgery Partners, Inc. (NASDAQ:SGRY) Shares Could Be 50% Below Their Intrinsic Value Estimate

Jan 24
Surgery Partners, Inc. (NASDAQ:SGRY) Shares Could Be 50% Below Their Intrinsic Value Estimate

We Think Surgery Partners (NASDAQ:SGRY) Is Taking Some Risk With Its Debt

Sep 26
We Think Surgery Partners (NASDAQ:SGRY) Is Taking Some Risk With Its Debt

The Returns On Capital At Surgery Partners (NASDAQ:SGRY) Don't Inspire Confidence

Aug 15
The Returns On Capital At Surgery Partners (NASDAQ:SGRY) Don't Inspire Confidence

Surgery Partners GAAP EPS of -$0.21 misses by $0.07, revenue of $615.4M misses by $3.61M

Aug 02

Surgery Partners And Alternative Near Cap-Gain Portfolio Wealth Builders

Jul 02

Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Jun 27
Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt

Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Mar 27
Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?

Is Surgery Partners (NASDAQ:SGRY) A Risky Investment?

Dec 06
Is Surgery Partners (NASDAQ:SGRY) A Risky Investment?

Ripartizione dei ricavi e delle spese

Come Surgery Partners guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

NasdaqGS:SGRY Ricavi, spese e utili (USD Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Jun 242,889-341310
31 Mar 242,79511220
31 Dec 232,743-121210
30 Sep 232,715-341290
30 Jun 232,662-541100
31 Mar 232,609-921050
31 Dec 222,539-551020
30 Sep 222,442-311010
30 Jun 222,381-291080
31 Mar 222,309-381070
31 Dec 212,225-811040
30 Sep 212,163-861010
30 Jun 212,100-1351000
31 Mar 211,932-1501010
31 Dec 201,860-156970
30 Sep 201,829-179970
30 Jun 201,785-132920
31 Mar 201,856-119900
31 Dec 191,831-110890
30 Sep 191,805-238870
30 Jun 191,786-243870
31 Mar 191,777-241900
31 Dec 181,772-238940
30 Sep 181,732-122840
30 Jun 181,597-125890
31 Mar 181,443-102790
31 Dec 171,312-79690
30 Sep 171,159-22710
30 Jun 171,1357600
31 Mar 171,13914560
31 Dec 161,1219550
30 Sep 161,0799600
30 Jun 161,0399580
31 Mar 169811560
31 Dec 159361560
30 Sep 15855-70460
30 Jun 15696-73420
31 Mar 15544-69360
31 Dec 14394-66310
31 Dec 13279-9260

Guadagni di qualità: SGRY al momento non è redditizia.

Margine di profitto in crescita: SGRY al momento non è redditizia.


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: SGRY non è redditizia, ma ha ridotto le perdite negli ultimi 5 anni a un tasso pari a 41% all'anno.

Accelerare la crescita: Impossibile confrontare la crescita degli utili di SGRY nell'ultimo anno con la sua media quinquennale poiché al momento non è redditizia

Guadagni vs Settore: SGRY non è redditizia, il che rende difficile confrontare la crescita dei suoi utili dell'anno passato con il settore Healthcare ( 6% ).


Rendimento del capitale proprio

ROE elevato: SGRY ha un Return on Equity negativo ( 3.57% ), in quanto al momento non è redditizio.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate